Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage
Richter, Johanna, Cork, Amanda J., Ong, Yvette, Keller, Nadia, Hayes, Andrew J., Schembri, Mark A., Jennison, Amy V., Davies, Mark R., Schroder, Kate, Walker, Mark J. and Brouwer, Stephan (2025). Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio, 16 (2) e0336624, e0336624. doi: 10.1128/mbio.03366-24
Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model
Rivera-Hernandez, Tania, Carnathan, Diane G., Richter, Johanna, Marchant, Patrick, Cork, Amanda J., Elangovan, Gayathiri, Henningham, Anna, Cole, Jason N., Choudhury, Biswa, Moyle, Peter M., Toth, Istvan, Batzloff, Michael R., Good, Michael F., Agarwal, Paresh, Kapoor, Neeraj, Nizet, Victor, Silvestri, Guido and Walker, Mark J. (2024). Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model. Vaccines, 12 (4) 382, 1-10. doi: 10.3390/vaccines12040382
Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies
Rivera-Hernandez, Tania, Rhyme, Mira Syahira, Cork, Amanda J., Jones, Scott, Segui-Perez, Celia, Brunner, Livia, Richter, Johanna, Petrovsky, Nikolai, Lawrenz, Maria, Goldblatt, David, Collin, Nicolas and Walker, Mark J. (2020). Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies. mBio, 11 (2) e00122-20. doi: 10.1128/mbio.00122-20
